lenalidomide has been researched along with Kaposi Sarcoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Aboulafia, D; Ambinder, RF; Baiocchi, R; Bui, JD; Chiao, EY; Dittmer, DP; Han, S; Martínez-Maza, O; Maurer, T; Mitsuyasu, R; Moore, P; Reid, EG; Shimabukuro, K; Wachsman, W | 1 |
| Henry, DH; Maki, RG | 1 |
| Bouscary, D; Chavarot, N; Karras, A; Lebbe, C; Thervet, E | 1 |
| Burg, S; Crickx, B; Di Lucca, J; Feldman, J; Joly, V; Lariven, S; Marinho, E; Maubec, E; Peytavin, G; Raymond, E; Sarda-Mantel, L; Steff, M | 1 |
| Assoumou, L; Balabanian, K; Boué, F; Carlotti, A; Deback, C; Desnoyer, A; Dupin, N; Gaudin, F; Marcelin, AG; Peytavin, G; Pourcher, V | 1 |
| Assoumou, L; Boué, F; Cardon, F; Chennebault, JM; Costagliola, D; Curjol, A; Desnoyer, A; Gibowski, S; Lebbe, C; Marcelin, AG; Peytavin, G; Poizot-Martin, I; Pourcher, V; Salmon, D | 1 |
| Boué, F; Castilla, MA; Kirstetter, M; Martinez, V; Melica, G; Tateo, M | 1 |
| Laffitte, E | 1 |
| De Aloe, G; Fimiani, M; Flori, ML; Rubegni, P; Sbano, P | 1 |
2 trial(s) available for lenalidomide and Kaposi Sarcoma
| Article | Year |
|---|---|
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Topics: Adult; Angiogenesis Inhibitors; Antigens, Viral; Biomarkers, Tumor; Case-Control Studies; Chemokine CXCL12; Female; Humans; Lenalidomide; Male; Nuclear Proteins; Receptors, CXCR; Receptors, CXCR4; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide; Vascular Endothelial Growth Factor A | 2016 |
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lenalidomide; Male; Middle Aged; Sarcoma, Kaposi; Thalidomide; Treatment Outcome; Young Adult | 2017 |
7 other study(ies) available for lenalidomide and Kaposi Sarcoma
| Article | Year |
|---|---|
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.
Topics: Cytokines; Herpesvirus 8, Human; HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi | 2022 |
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.
Topics: HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi | 2022 |
Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports.
Topics: Aged; Amyloidosis; Antineoplastic Agents; Bortezomib; Female; Humans; Immunologic Factors; Lenalidomide; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2017 |
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antiretroviral Therapy, Highly Active; Black People; CD4 Lymphocyte Count; Compassionate Use Trials; HIV-1; Humans; Lenalidomide; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Sarcoma, Kaposi; Thalidomide; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Viral Load | 2013 |
Lenalidomide in treating AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; HIV-1; Humans; Lenalidomide; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2011 |
Thalidomide in Kaposi sarcoma: promising or disappointing?
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Lenalidomide; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2007 |
Thalidomide in the treatment of Kaposi's sarcoma.
Topics: Antineoplastic Agents; Humans; Lenalidomide; Sarcoma, Kaposi; Thalidomide | 2007 |